... The Rapid-Screen cDNA Library Panels were designe...ree sets of PCRs to identify the desired cDNA clon...l "Master Plate," where each well contains plasmid...tive well(s) by gel electrophoresis of the reactio...
... Idaho Technologys R.A.P.I.D. System (Ruggedized A...d, real-time, PCR thermocycler designed for field ...ironments. In addition to its ruggedness, it is de...e LightCycler instrument. By taking advantage of t...
... The Rapid-Screen cDNA Library Panels were designe...ree sets of PCRs to identify the desired cDNA clon...l "Master Plate," where each well contains plasmid...tive well(s) by gel electrophoresis of the reactio...
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
Biology Products:(Date:11/30/2009)...0 The Michael J. Fox Fo...ounced $1.5 million in total awards to six researc...ifying therapies for Parkinson,s disease. The fund...g Discovery for Parkinson,s Disease program, made...YSE: ELN ), a neuroscience-based biotechnology c...
(Date:11/30/2009)...ovember 30 Biopharmaceutical compa...tients have been enrolled in its,multinational reg...is,designed to show reduction in transplant relate...geneic stem cell transplantation with a mismatched...eligible for an allogeneic,stem cell transplantati...
(Date:11/30/2009)...Nov. 30 Novavax, Inc. (N...rollment in the Phase II clinical study of its tri...trains) VLP vaccine candidate in healthy adults 60...mized, double-blind, active-controlled study is co...y of two different doses (15 mcg and 60 mcg) of No...
(Date:11/30/2009)...v. 30 Cell Therapeutics,... that its new class of platinum-based anti-tumor c...ronger anti-tumor potency and activity compared to...ell as the ability to overcome cisplatin-resistanc...d in a paper titled "Novel Bis-platinum Complexes ...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3